Buoyed by Positive Trial Data, Private Yaupon Prepares To File Topical Chemo For Early CTCL

FDA orphan R&D grant and academic ties start to pay off for biotech's lead drug, a topical gel of a generic chemotherapy aimed at 20,000 patients with early-stage skin cancer.